SCHEMBL6684555

SCHEMBL6684555

CN(c1ccncc1)c1ccccc1C(=O)NN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ MPO P05164 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2A6 P11509 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ MMP9 P14780 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ CTSD P07339 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPK1 P28482 1/20 0.40
▸ TYK2 P29597 2/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636255 0.81 KDM4E (0.46) KDM4EMMP9MMP13ALDH1A1KMT2A
SCHEMBL962276 0.77 ALDH1A1 (0.62) P2RX7KDM4ECTSDALDH1A1CA1
SCHEMBL6683811 0.77 TSHR (0.54) ALDH1A1MAPK1L3MBTL1KMT2AMEN1
SCHEMBL10836959 0.75 HTT (0.48) KDM4EALDH1A1KMT2AMEN1HSD17B10
SCHEMBL959908 0.71 CTSD (0.50) P2RX7KDM4ECTSDALDH1A1CA1
SCHEMBL961664 0.71 CTSD (0.50) P2RX7KDM4ECTSDALDH1A1CA1
SCHEMBL10921933 0.71 CTSD (0.49) P2RX7KDM4ECTSDALDH1A1CA1
SCHEMBL31087643 0.70 ALDH1A1 (0.62) P2RX7KDM4EMPOCYP1A2CYP3A4
SCHEMBL28086048 0.70 ALDH1A1 (0.62) P2RX7KDM4EMPOCYP1A2CYP3A4
SCHEMBL2762268 0.69 MAPT (0.46) KDM4ECYP3A4CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004052280-A2 ANTI-ANGIOGENIC COMPOUNDS AND THEIR USE IN CANCER TREATMENT IMCLONE SYSTEMS INCORPORATED (US) 2004-06-24 — — WO disclosed
Send feedback